1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Anti-inflammatories Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Anti-inflammatories Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Anti-inflammatories Overall Market Size
2.1 Global Ophthalmic Anti-inflammatories Market Size: 2022 VS 2029
2.2 Global Ophthalmic Anti-inflammatories Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ophthalmic Anti-inflammatories Sales: 2018-2029
3 Company Landscape
3.1 Top Ophthalmic Anti-inflammatories Players in Global Market
3.2 Top Global Ophthalmic Anti-inflammatories Companies Ranked by Revenue
3.3 Global Ophthalmic Anti-inflammatories Revenue by Companies
3.4 Global Ophthalmic Anti-inflammatories Sales by Companies
3.5 Global Ophthalmic Anti-inflammatories Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ophthalmic Anti-inflammatories Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ophthalmic Anti-inflammatories Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmic Anti-inflammatories Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmic Anti-inflammatories Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmic Anti-inflammatories Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ophthalmic Anti-inflammatories Market Size Markets, 2022 & 2029
4.1.2 Antibacterial
4.1.3 Antiviral
4.1.4 Antifungal
4.1.5 Anti-Parasitic
4.1.6 Others
4.2 By Type – Global Ophthalmic Anti-inflammatories Revenue & Forecasts
4.2.1 By Type – Global Ophthalmic Anti-inflammatories Revenue, 2018-2023
4.2.2 By Type – Global Ophthalmic Anti-inflammatories Revenue, 2024-2029
4.2.3 By Type – Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
4.3 By Type – Global Ophthalmic Anti-inflammatories Sales & Forecasts
4.3.1 By Type – Global Ophthalmic Anti-inflammatories Sales, 2018-2023
4.3.2 By Type – Global Ophthalmic Anti-inflammatories Sales, 2024-2029
4.3.3 By Type – Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
4.4 By Type – Global Ophthalmic Anti-inflammatories Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ophthalmic Anti-inflammatories Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Ophthalmic Anti-inflammatories Revenue & Forecasts
5.2.1 By Application – Global Ophthalmic Anti-inflammatories Revenue, 2018-2023
5.2.2 By Application – Global Ophthalmic Anti-inflammatories Revenue, 2024-2029
5.2.3 By Application – Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
5.3 By Application – Global Ophthalmic Anti-inflammatories Sales & Forecasts
5.3.1 By Application – Global Ophthalmic Anti-inflammatories Sales, 2018-2023
5.3.2 By Application – Global Ophthalmic Anti-inflammatories Sales, 2024-2029
5.3.3 By Application – Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
5.4 By Application – Global Ophthalmic Anti-inflammatories Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ophthalmic Anti-inflammatories Market Size, 2022 & 2029
6.2 By Region – Global Ophthalmic Anti-inflammatories Revenue & Forecasts
6.2.1 By Region – Global Ophthalmic Anti-inflammatories Revenue, 2018-2023
6.2.2 By Region – Global Ophthalmic Anti-inflammatories Revenue, 2024-2029
6.2.3 By Region – Global Ophthalmic Anti-inflammatories Revenue Market Share, 2018-2029
6.3 By Region – Global Ophthalmic Anti-inflammatories Sales & Forecasts
6.3.1 By Region – Global Ophthalmic Anti-inflammatories Sales, 2018-2023
6.3.2 By Region – Global Ophthalmic Anti-inflammatories Sales, 2024-2029
6.3.3 By Region – Global Ophthalmic Anti-inflammatories Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.4.2 By Country – North America Ophthalmic Anti-inflammatories Sales, 2018-2029
6.4.3 US Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.4.4 Canada Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.4.5 Mexico Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.5.2 By Country – Europe Ophthalmic Anti-inflammatories Sales, 2018-2029
6.5.3 Germany Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.4 France Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.5 U.K. Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.6 Italy Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.7 Russia Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.8 Nordic Countries Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.5.9 Benelux Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.6.2 By Region – Asia Ophthalmic Anti-inflammatories Sales, 2018-2029
6.6.3 China Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.4 Japan Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.5 South Korea Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.6 Southeast Asia Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.6.7 India Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.7.2 By Country – South America Ophthalmic Anti-inflammatories Sales, 2018-2029
6.7.3 Brazil Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.7.4 Argentina Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ophthalmic Anti-inflammatories Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ophthalmic Anti-inflammatories Sales, 2018-2029
6.8.3 Turkey Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8.4 Israel Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8.5 Saudi Arabia Ophthalmic Anti-inflammatories Market Size, 2018-2029
6.8.6 UAE Ophthalmic Anti-inflammatories Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Ophthalmic Anti-inflammatories Major Product Offerings
7.1.4 Novartis Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Valeant Pharmaceuticals
7.2.1 Valeant Pharmaceuticals Company Summary
7.2.2 Valeant Pharmaceuticals Business Overview
7.2.3 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Major Product Offerings
7.2.4 Valeant Pharmaceuticals Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.2.5 Valeant Pharmaceuticals Key News & Latest Developments
7.3 Allergan
7.3.1 Allergan Company Summary
7.3.2 Allergan Business Overview
7.3.3 Allergan Ophthalmic Anti-inflammatories Major Product Offerings
7.3.4 Allergan Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.3.5 Allergan Key News & Latest Developments
7.4 Santen Pharmaceutical
7.4.1 Santen Pharmaceutical Company Summary
7.4.2 Santen Pharmaceutical Business Overview
7.4.3 Santen Pharmaceutical Ophthalmic Anti-inflammatories Major Product Offerings
7.4.4 Santen Pharmaceutical Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.4.5 Santen Pharmaceutical Key News & Latest Developments
7.5 Lupin Pharmaceuticals
7.5.1 Lupin Pharmaceuticals Company Summary
7.5.2 Lupin Pharmaceuticals Business Overview
7.5.3 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Major Product Offerings
7.5.4 Lupin Pharmaceuticals Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.5.5 Lupin Pharmaceuticals Key News & Latest Developments
7.6 Apotex
7.6.1 Apotex Company Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Ophthalmic Anti-inflammatories Major Product Offerings
7.6.4 Apotex Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.6.5 Apotex Key News & Latest Developments
7.7 Akorn
7.7.1 Akorn Company Summary
7.7.2 Akorn Business Overview
7.7.3 Akorn Ophthalmic Anti-inflammatories Major Product Offerings
7.7.4 Akorn Ophthalmic Anti-inflammatories Sales and Revenue in Global (2018-2023)
7.7.5 Akorn Key News & Latest Developments
8 Global Ophthalmic Anti-inflammatories Production Capacity, Analysis
8.1 Global Ophthalmic Anti-inflammatories Production Capacity, 2018-2029
8.2 Ophthalmic Anti-inflammatories Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmic Anti-inflammatories Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmic Anti-inflammatories Supply Chain Analysis
10.1 Ophthalmic Anti-inflammatories Industry Value Chain
10.2 Ophthalmic Anti-inflammatories Upstream Market
10.3 Ophthalmic Anti-inflammatories Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmic Anti-inflammatories Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の眼科用抗炎症薬市場予測2023-2029：抗菌、抗ウイルス、抗真菌、抗寄生虫、その他 |
| 【英語タイトル】Ophthalmic Anti-inflammatories Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5832 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：76 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の眼科用抗炎症薬市場規模と予測を収録しています。・世界の眼科用抗炎症薬市場：売上、2018年-2023年、2024年-2029年 ・世界の眼科用抗炎症薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の眼科用抗炎症薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗菌」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 眼科用抗炎症薬のグローバル主要企業は、Novartis、 Valeant Pharmaceuticals、 Allergan、 Santen Pharmaceutical、 Lupin Pharmaceuticals、 Apotex、 Akornなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、眼科用抗炎症薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の眼科用抗炎症薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の眼科用抗炎症薬市場：タイプ別市場シェア、2022年 ・抗菌、抗ウイルス、抗真菌、抗寄生虫、その他 世界の眼科用抗炎症薬市場：用途別、2018年-2023年、2024年-2029年 世界の眼科用抗炎症薬市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の眼科用抗炎症薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の眼科用抗炎症薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における眼科用抗炎症薬のグローバル売上、2018年-2023年 ・主要企業における眼科用抗炎症薬のグローバル売上シェア、2022年 ・主要企業における眼科用抗炎症薬のグローバル販売量、2018年-2023年 ・主要企業における眼科用抗炎症薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis、 Valeant Pharmaceuticals、 Allergan、 Santen Pharmaceutical、 Lupin Pharmaceuticals、 Apotex、 Akorn ************************************************************* ・調査・分析レポートの概要 眼科用抗炎症薬市場の定義 市場セグメント 世界の眼科用抗炎症薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の眼科用抗炎症薬市場規模 世界の眼科用抗炎症薬市場規模：2022年 VS 2029年 世界の眼科用抗炎症薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの眼科用抗炎症薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の眼科用抗炎症薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：抗菌、抗ウイルス、抗真菌、抗寄生虫、その他 眼科用抗炎症薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 眼科用抗炎症薬の用途別グローバル売上・予測 ・地域別市場分析 地域別眼科用抗炎症薬市場規模 2022年と2029年 地域別眼科用抗炎症薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis、 Valeant Pharmaceuticals、 Allergan、 Santen Pharmaceutical、 Lupin Pharmaceuticals、 Apotex、 Akorn ... |
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Anti-inflammatories, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Anti-inflammatories. This report contains market size and forecasts of Ophthalmic Anti-inflammatories in global, including the following market information:
Global Ophthalmic Anti-inflammatories Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmic Anti-inflammatories Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ophthalmic Anti-inflammatories companies in 2022 (%)
The global Ophthalmic Anti-inflammatories market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antibacterial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Anti-inflammatories include Novartis, Valeant Pharmaceuticals, Allergan, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmic Anti-inflammatories manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Anti-inflammatories Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Anti-inflammatories Market Segment Percentages, by Type, 2022 (%)
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Global Ophthalmic Anti-inflammatories Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Anti-inflammatories Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Ophthalmic Anti-inflammatories Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmic Anti-inflammatories Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Anti-inflammatories revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmic Anti-inflammatories revenues share in global market, 2022 (%)
Key companies Ophthalmic Anti-inflammatories sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ophthalmic Anti-inflammatories sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Valeant Pharmaceuticals
Allergan
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Anti-inflammatories, market overview.
Chapter 2: Global Ophthalmic Anti-inflammatories market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Anti-inflammatories manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Anti-inflammatories in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Anti-inflammatories capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の眼科用抗炎症薬市場予測2023-2029：抗菌、抗ウイルス、抗真菌、抗寄生虫、その他] (コード：MMG23JU5832)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の眼科用抗炎症薬市場予測2023-2029：抗菌、抗ウイルス、抗真菌、抗寄生虫、その他]についてメールでお問い合わせ |
